ACS
Desconocido
EuroNeurotrophin: A European training network for the discovery of neurotrophins small molecule mimetics as candidate...
AvantiCell Science Ltd
participó en un
H2020:
H2020-MSCA-ITN-2017
Neurodegenerative diseases (ND) like AD, PD, MS and ALS/MND are on the rise in developed societies worldwide. Currently, there exists no cu...
2017-08-17 - 2022-03-31 | Financiado
2017-08-17 - 2022-03-31 | Financiado
CENSUS: Cell Based Models for Neurodegeneration Study and Use in Screening
AvantiCell Science Ltd
tramitó un
H2020:
H2020-FTIPilot-2016
1. Treatment of neurodegenerative disease is an unmet clinical challenge and patient care is a growing, unsustainable global healthcare burd...
2016-09-13 - 2019-09-30 | Financiado
2016-09-13 - 2019-09-30 | Financiado
TRANSMIT: TRANSlating the role of Mitochondria in Tumorigenesis
AvantiCell Science Ltd
participó en un
H2020:
H2020-MSCA-ITN-2016
The consolidation of the knowledge that cancer is not only a genetic, but also a metabolic disease, has led scientists to investigate the in...
2016-08-16 - 2021-06-30 | Financiado
2016-08-16 - 2021-06-30 | Financiado
ANAPRINT: Additive Printing for Cell Based Analysis
AvantiCell Science Ltd
tramitó un
H2020:
H2020-SMEInst-2014-2015
The Project shall develop a unique manufacturing solution for the automated production of complex cell models widely used by industry to tes...
2015-10-11 - 2018-10-31 | Financiado
2015-10-11 - 2018-10-31 | Financiado
PANDORA: Probing safety of nano objects by defining immune responses of environmental organisms
AvantiCell Science Ltd
participó en un
H2020:
H2020-MSCA-ITN-2015
PANDORA (Probing safety of nano-objects by defining immune responses of environmental organisms) shall assess the global impact of engineere...
2015-08-10 - 2019-12-31 | Financiado
2015-08-10 - 2019-12-31 | Financiado
Chromatin3D: Chromatin Dynamics in Development and Disease
AvantiCell Science Ltd
participó en un
H2020:
H2020-MSCA-ITN-2014
The cell nucleus is organized and compartmentalized into a highly ordered structure that contains DNA, RNA, chromosomal and histone proteins...
2014-12-12 - 2018-12-31 | Financiado
2014-12-12 - 2018-12-31 | Financiado
ANAPRINT: Additive Printing for Cell based Analysis
AvantiCell Science Ltd
tramitó un
H2020:
H2020-SMEInst-2014-2015
The Project will develop and commercialise the additive printing of cell-based analysis systems. The objective is to deliver consistent, sca...
2014-09-15 - 2015-03-31 | Financiado
2014-09-15 - 2015-03-31 | Financiado
PathChooser: Innovative mechanistic based strategies for delivery of therapeutic macromolecules across cellular...
AvantiCell Science Ltd
participó en un
FP7:
Nanomedicine offers capability to significantly change the course of treatment for life-threatening diseases. Many of the most significant c...
Financiado
Financiado
MAGISTER: Magnetic Scaffolds for in vivo Tissue Engineering
AvantiCell Science Ltd
participó en un
FP7:
The main driving idea of the project is the creation of conceptually new type of scaffolds able to be manipulated in situ by means of magnet...
Financiado
Financiado
NEXT: Nano Engineering for Cross Tolerance new approach for bioengineered vascularised chimeric islet t...
AvantiCell Science Ltd
participó en un
FP7:
Diabetes is caused by insufficient or lack of insulin secretion by the specialized B cells of the pancreas and, if not treated adequately ev...
Financiado
Financiado
HUMUNITY: Cell Based Models of Human Mucosal Immunity with Multiple Commercial Applications
AvantiCell Science Ltd
participó en un
FP7:
HUMUNITY is a PhD school which shall train young scientists in novel approaches to the study of human mucosal immunity by the use of advance...
Financiado
Financiado
NANOTOES: Nanotechnology Training Of Experts in Safety
AvantiCell Science Ltd
participó en un
FP7:
Life Sciences and Nano Sciences interact today mainly in two areas: in the evaluation of accidental health and environmental effects derived...
Financiado
Financiado
BIOSID: A bioartificial pancreas to treat type 1 diabetes optimization of cell survival and function in pre...
AvantiCell Science Ltd
participó en un
FP7:
MAILPAN (MAcroencapsulation of PANcreatic Islets) is a prototype of bioartificial pancreas usable in the human designed to treat type 1 diab...
Financiado
Financiado
* No se disponen de datos de la empresa actual.